As of the latest Form 4 filed Jun 15, 2026.
What Health Catalyst Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Newest filing first — the 28 most recent filings for HCAT.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | 2026-06-10 | Albert Benjamin CEO | FTax | −34.5K | $1.69 | $58.3K | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Albert Benjamin CEO | FTax | −336.00 | $1.37 | $460.39 | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Landry Benjamin General Counsel | FTax | −13.8K | $1.37 | $18.9K | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Alger Jason Chief Financial Officer | FTax | −18.8K | $1.37 | $25.8K | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Larson-Green Julie Director | AAward | +12.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Llewelyn Linda Chief People Officer | FTax | −8.52K | $1.37 | $11.7K | No | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | Nelson Steven H Director | AAward | +155K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-01 | 2026-05-01 | Albert Benjamin CEO | FTax | −310.00 | $1.35 | $416.95 | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-29 | Albert Benjamin, CEO | AAward | +1.12K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-13 | 2026-03-10 | Albert Benjamin CEO | FTax | −70.5K | $1.85 | $130K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-02 | Albert Benjamin CEO | FTax | −4.97K | $1.66 | $8.24K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-02 | Landry Benjamin General Counsel | FTax | −20.8K | $1.66 | $34.6K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-02 | Alger Jason Chief Financial Officer | FTax | −27.0K | $1.66 | $44.8K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-02 | Llewelyn Linda Chief People Officer | FTax | −13.8K | $1.66 | $23.0K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-01 | Larson-Green Julie Director | AAward | +8.36K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Albert Benjamin CEO | FTax | −13.3K | $1.75 | $23.3K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Landry Benjamin General Counsel | FTax | −6.32K | $1.75 | $11.0K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Alger Jason Chief Financial Officer | FTax | −7.52K | $1.75 | $13.1K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Llewelyn Linda Chief People Officer | FTax | −4.47K | $1.75 | $7.81K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Albert Benjamin CEO | AAward | +38.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Albert Benjamin, CEO | AAward | +930K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Landry Benjamin General Counsel | AAward | +16.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Landry Benjamin, General Counsel | AAward | +289K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Alger Jason Chief Financial Officer | AAward | +22.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Alger Jason, Chief Financial Officer | AAward | +508K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Llewelyn Linda Chief People Officer | AAward | +13.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Llewelyn Linda, Chief People Officer | AAward | +192K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-17 | Gallagher Duncan Director | AAward | +7.56K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also HCAT’s full analysis or the market-wide insider trading feed. The tabs above jump to HCAT’s other SEC data.
Source: SEC Form 4 filings for HCAT, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.